Literature DB >> 28565793

Involvement of neuronal pathways in the protective effects of hindlimb perconditioning during renal ischemia.

Zahra Sedaghat1, Mehri Kadkhodaee2, Behjat Seifi2, Parisa Ahghari3, Khalil Pourkhalili1, Zahra Akbari1, Mehdi Sadeghi1.   

Abstract

Remote ischemic perconditioning (RPEC) is a therapeutic intervention that has been demonstrated to reduce renal ischemia/reperfusion (I/R) injury. However, the underlying renal protective mechanism remains unclear. The present study hypothesized that RPEC may utilize neural pathways to transfer the protective signal from the perconditioned hindlimb to the kidney. Following a right nephrectomy, rats were randomly allocated into five groups (n=6). The sham group underwent the surgical protocol only. In all other groups, the left renal pedicle was clamped for 45 min and reperfused for 24 h. The I/R control group then underwent 45 min ischemia and 24 h reperfusion (I/R) with no more intervention but the I/R-NR control group underwent the ischemia and reperfusion followed by left femoral nerve (FN) and sciatic nerve (SN) resection. The RPEC group underwent ischemia and reperfusion followed by four cycles of 5 min occlusions of the left femoral artery and 5 min reperfusion. Finally, the RPEC-NR group underwent ischemia and reperfusion followed by left FN and SN resection. Following 24 h, renal functional indices, plasma blood urea nitrogen (BUN) and creatinine (Cr) levels, urinary N-acetyl-β-glucosaminidase (NAG) release and histopathological changes were assessed. Compared with the sham group, ischemia and reperfusion in the sham and I/R control groups resulted in renal dysfunction, indicated by significantly increased levels of BUN and Cr. This was accompanied by increased urinary NAG activity and morphological damage observed in control groups. In the RPEC group, renal histology and function were significantly improved compared with the control groups. However, FN and SN resection eliminated the protection of the kidney, which was induced by RPEC. In conclusion, remote hindlimb ischemic perconditioning reduced renal I/R injury in the rat kidney in a manner that potentially involves a neural pathway.

Entities:  

Keywords:  ischemia/reperfusion; kidney; neuronal pathways; perconditioning; remote organ

Year:  2017        PMID: 28565793      PMCID: PMC5443195          DOI: 10.3892/etm.2017.4175

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  26 in total

1.  Morphine may enhance the cardioprotection induced by remote ischemic perconditioning.

Authors:  Yao Lu; Jun Hu; Chunshan Dong
Journal:  Int J Cardiol       Date:  2015-03-26       Impact factor: 4.164

2.  The neural and humoral pathways in remote limb ischemic preconditioning.

Authors:  Shiang Y Lim; Derek M Yellon; Derek J Hausenloy
Journal:  Basic Res Cardiol       Date:  2010-05-07       Impact factor: 17.165

Review 3.  Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery.

Authors:  Marianne Schmid; Deepansh Dalela; Rana Tahbaz; Jessica Langetepe; Marco Randazzo; Roland Dahlem; Margit Fisch; Quoc-Dien Trinh; Felix K-H Chun
Journal:  World J Nephrol       Date:  2015-05-06

4.  Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways.

Authors:  Andreas Skyschally; Sabine Gent; Georgios Amanakis; Christiane Schulte; Petra Kleinbongard; Gerd Heusch
Journal:  Circ Res       Date:  2015-06-09       Impact factor: 17.367

5.  Hepatoprotective effects of remote perconditioning during renal ischemia.

Authors:  Z Sedaghat; M Kadkhodaee; B Seifi; P Ahghari
Journal:  Bratisl Lek Listy       Date:  2014       Impact factor: 1.278

Review 6.  New insights into the mechanisms of acute kidney injury in the intensive care unit.

Authors:  Seth D Glodowski; Gebhard Wagener
Journal:  J Clin Anesth       Date:  2014-12-03       Impact factor: 9.452

7.  Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils.

Authors:  Mikiko Shimizu; Pankaj Saxena; Igor E Konstantinov; Vera Cherepanov; Michael M H Cheung; Peter Wearden; Hua Zhangdong; Michael Schmidt; Gregory P Downey; Andrew N Redington
Journal:  J Surg Res       Date:  2010-01       Impact factor: 2.192

8.  Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity.

Authors:  E Horak; S M Hopfer; F W Sunderman
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

Review 9.  Ischaemic conditioning and reperfusion injury.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

Review 10.  Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis.

Authors:  Jiachang Hu; Shaopeng Liu; Ping Jia; Xialian Xu; Nana Song; Ting Zhang; Rongyi Chen; Xiaoqiang Ding
Journal:  Crit Care       Date:  2016-04-20       Impact factor: 9.097

View more
  3 in total

1.  Scintigraphic evaluation of remote pre-conditioning protection against unilateral renal ischemia/reperfusion injury in rats: a longitudinal study.

Authors:  Zahra Sedaghat; Hossein Fatemikia; Kaveh Tanha; Maria Zahiri; Majid Assadi
Journal:  Int Urol Nephrol       Date:  2019-08-12       Impact factor: 2.370

2.  Impact of combined ischemic preconditioning and remote ischemic perconditioning on ischemia-reperfusion injury after liver transplantation.

Authors:  Ding-Yang Li; Wen-Tao Liu; Guang-Yi Wang; Xiao-Ju Shi
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

3.  The role of nitric oxide in the protective action of remote ischemic per-conditioning against ischemia/reperfusion-induced acute renal failure in rat.

Authors:  Firouzeh Gholampour; Leila Khangah; Jafar Vatanparast; Hamid Reza Karbalaei-Heidari; Seyed Mohammad Owji; Aminollah Bahaoddini
Journal:  Iran J Basic Med Sci       Date:  2018-06       Impact factor: 2.699

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.